These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 37189717)
21. Characterization of CD44 variant expression in head and neck squamous cell carcinomas. Spiegelberg D; Kuku G; Selvaraju R; Nestor M Tumour Biol; 2014 Mar; 35(3):2053-62. PubMed ID: 24122205 [TBL] [Abstract][Full Text] [Related]
22. Development of a sandwich enzyme-linked immunosorbent assay for the detection of CD44v3 using exon v3- and v6-specific monoclonal antibody pairs. Jeoung MH; Kim TK; Shim H; Lee S J Immunol Methods; 2016 Sep; 436():22-8. PubMed ID: 27288967 [TBL] [Abstract][Full Text] [Related]
23. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348 [TBL] [Abstract][Full Text] [Related]
24. CD44 related stemness maneuvers oral squamous cell carcinoma biology. Tandon A; Singh NN; Gulati N Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358 [TBL] [Abstract][Full Text] [Related]
25. PMab-235: A monoclonal antibody for immunohistochemical analysis against goat podoplanin. Furusawa Y; Yamada S; Nakamura T; Sano M; Sayama Y; Itai S; Takei J; Harada H; Fukui M; Kaneko MK; Kato Y Heliyon; 2019 Jul; 5(7):e02063. PubMed ID: 31338471 [TBL] [Abstract][Full Text] [Related]
26. CD44 in normal human pancreas and pancreatic carcinoma cell lines. Ringel J; Jesnowski R; Schmidt C; Ringel J; Köhler HJ; Rychly J; Batra SK; Löhr M Teratog Carcinog Mutagen; 2001; 21(1):97-106. PubMed ID: 11135324 [TBL] [Abstract][Full Text] [Related]
27. CD44 standard and variant isoform expression in human epidermal skin tumors is not correlated with tumor aggressiveness but down-regulated during proliferation and tumor de-differentiation. Seelentag WK; Günthert U; Saremaslani P; Futo E; Pfaltz M; Heitz PU; Roth J Int J Cancer; 1996 Jun; 69(3):218-24. PubMed ID: 8682591 [TBL] [Abstract][Full Text] [Related]
28. CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma. Todoroki K; Ogasawara S; Akiba J; Nakayama M; Naito Y; Seki N; Kusukawa J; Yano H Int J Oncol; 2016 Jan; 48(1):99-109. PubMed ID: 26647656 [TBL] [Abstract][Full Text] [Related]
29. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers. Nanamiya R; Suzuki H; Kaneko MK; Kato Y Monoclon Antib Immunodiagn Immunother; 2023 Oct; 42(5):166-177. PubMed ID: 37824755 [TBL] [Abstract][Full Text] [Related]
30. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas. Tran TA; Kallakury BV; Sheehan CE; Ross JS Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of CD44 variant expression in oral, head and neck squamous cell carcinomas using a triple approach and its clinical significance. Athanassiou-Papaefthymiou M; Shkeir O; Kim D; Divi V; Matossian M; Owen JH; Czerwinski MJ; Papagerakis P; McHugh J; Bradford CR; Carey TE; Wolf GT; Prince ME; Papagerakis S Int J Immunopathol Pharmacol; 2014; 27(3):337-49. PubMed ID: 25280025 [TBL] [Abstract][Full Text] [Related]
32. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma. Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409 [TBL] [Abstract][Full Text] [Related]